Wellington Management Group LLP Arrowhead Pharmaceuticals, Inc. Transaction History

Wellington Management Group LLP

$545 Billion
Q3 2025

A detailed history of Wellington Management Group LLP transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 49,442 shares of ARWR stock, worth $2.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

49,442

Previous 48,285 2.4%

Holding current value

$2.04 Million

Previous $762,000 123.75%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$14.71 - $34.49 $17,019 - $39,904	1,157 Added 2.4%	49,442 $1.71 Million
Q2 2025 Aug 14, 2025	SELL	$9.99 - $16.97 $43,246 - $73,463	-4,329 Reduced 8.23%	48,285 $762,000
Q1 2025 May 13, 2025	BUY	$12.74 - $21.53 $670,302 - $1.13 Million	52,614 New	52,614 $670,000
Q4 2024 Feb 12, 2025	SELL	$17.7 - $26.34 $115,191 - $171,420	-6,508 Reduced 10.51%	55,396 $1.04 Million
Q3 2024 Nov 14, 2024	BUY	$19.36 - $29.54 $17,152 - $26,172	886 Added 1.45%	61,904 $1.2 Million

Q2 2024 Aug 13, 2024	BUY	$21.87 - $28.24 $219,902 - $283,953	10,055 Added 19.73%	61,018 $1.59 Million
Q1 2024 May 15, 2024	BUY	$27.21 - $39.48 $1.39 Million - $2.01 Million	50,963 New	50,963 $1.46 Million
Q4 2023 Feb 12, 2024	BUY	$21.2 - $31.03 $295,443 - $432,434	13,936 New	13,936 $426,000
Q1 2023 May 12, 2023	SELL	$23.68 - $38.51 $319,348 - $519,345	-13,486 Reduced 31.52%	29,297 $744,000
Q4 2022 Feb 13, 2023	SELL	$28.0 - $40.56 $47,824 - $69,276	-1,708 Reduced 3.84%	42,783 $1.74 Million
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $4.63 Million - $7.54 Million	-156,094 Reduced 77.82%	44,491 $1.47 Million
Q2 2022 Aug 15, 2022	BUY	$27.79 - $50.61 $1 Million - $1.82 Million	35,998 Added 21.87%	200,585 $7.06 Million
Q1 2022 May 16, 2022	SELL	$39.62 - $69.97 $1.81 Million - $3.2 Million	-45,695 Reduced 21.73%	164,587 $7.57 Million
Q4 2021 Feb 11, 2022	BUY	$58.09 - $82.51 $170,552 - $242,249	2,936 Added 1.42%	210,282 $13.9 Million
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $23.1 Million - $33.7 Million	-396,072 Reduced 65.64%	207,346 $12.9 Million
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $13.3 Million - $19.3 Million	213,554 Added 54.78%	603,418 $50 Million
Q1 2021 May 17, 2021	SELL	$61.35 - $90.47 $3.46 Million - $5.11 Million	-56,477 Reduced 12.65%	389,864 $25.9 Million
Q4 2020 Feb 12, 2021	BUY	$43.82 - $85.37 $4.63 Million - $9.02 Million	105,688 Added 31.03%	446,341 $34.2 Million
Q3 2020 Nov 16, 2020	BUY	$33.21 - $51.27 $11.3 Million - $17.5 Million	340,653 New	340,653 $14.7 Million
Q1 2020 May 14, 2020	SELL	$20.56 - $63.12 $908,011 - $2.79 Million	-44,164 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$28.14 - $73.01 $1.24 Million - $3.22 Million	44,164 New	44,164 $2.8 Million

Others Institutions Holding ARWR

# of Institutions

339

Shares Held

103M

Call Options Held

953K

Put Options Held

263K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $4.37B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Arrowhead Pharmaceuticals, Inc. Transaction History